Cargando…
Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
Changes in glycosylation during tumour progression are a key hallmark of cancer. One of the glycan moieties generally overexpressed in cancer are sialic acids, which can induce immunomodulatory properties via binding to Siglec receptors. We here show that Pancreatic Ductal Adenocarcinoma (PDAC) tumo...
Autores principales: | Rodriguez, Ernesto, Boelaars, Kelly, Brown, Kari, Eveline Li, R. J., Kruijssen, Laura, Bruijns, Sven C. M., van Ee, Thomas, Schetters, Sjoerd T. T., Crommentuijn, Matheus H. W., van der Horst, Joost C., van Grieken, Nicole C. T., van Vliet, Sandra J., Kazemier, Geert, Giovannetti, Elisa, Garcia-Vallejo, Juan J., van Kooyk, Yvette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904912/ https://www.ncbi.nlm.nih.gov/pubmed/33627655 http://dx.doi.org/10.1038/s41467-021-21550-4 |
Ejemplares similares
-
Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions
por: Lübbers, Joyce, et al.
Publicado: (2018) -
Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
por: Chan, Chilam, et al.
Publicado: (2023) -
Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and
identification of Siglec-10 as an alternative receptor for porcine reproductive
and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017) -
Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021) -
Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)